|
RAB8B expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.987100E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.444700E-04 |
| Normal-vs-Stage2 |
3.889800E-02 |
| Normal-vs-Stage3 |
3.330000E-02 |
| Normal-vs-Stage4 |
6.726200E-02 |
| Stage1-vs-Stage2 |
7.063400E-01 |
| Stage1-vs-Stage3 |
4.278200E-01 |
| Stage1-vs-Stage4 |
3.511200E-01 |
| Stage2-vs-Stage3 |
4.517000E-01 |
| Stage2-vs-Stage4 |
3.977600E-01 |
| Stage3-vs-Stage4 |
8.694000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.959560E-04 |
| Normal-vs-AfricanAmerican |
7.160600E-01 |
| Normal-vs-Asian |
2.850200E-02 |
| Caucasian-vs-AfricanAmerican |
1.583910E-04 |
| Caucasian-vs-Asian |
5.134800E-01 |
| AfricanAmerican-vs-Asian |
2.103700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.994310E-04 |
| Normal-vs-Female |
4.443500E-02 |
| Male-vs-Female |
4.364400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.372980E-01 |
| Normal-vs-Age(41-60Yrs) |
1.015800E-03 |
| Normal-vs-Age(61-80Yrs) |
3.924500E-03 |
| Normal-vs-Age(81-100Yrs) |
2.195800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.215000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.835000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.314000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.084800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.358800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.346400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.869900E-02 |
| Normal-vs-Grade 2 |
1.416020E-04 |
| Normal-vs-Grade 3 |
1.270150E-02 |
| Normal-vs-Grade 4 |
8.589800E-02 |
| Grade 1-vs-Grade 2 |
9.192800E-01 |
| Grade 1-vs-Grade 3 |
3.424800E-01 |
| Grade 1-vs-Grade 4 |
4.036600E-01 |
| Grade 2-vs-Grade 3 |
2.824200E-02 |
| Grade 2-vs-Grade 4 |
2.284000E-01 |
| Grade 3-vs-Grade 4 |
8.952400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.69669999999989E-05 |
| Normal-vs-ccB subtype |
3.758700E-03 |
| ccA subtype-vs-ccB subtype |
2.954000E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.984710E-03 |
| Normal-vs-N1 |
1.341590E-01 |
| N0-vs-N1 |
4.084000E-01 |
|
|
